Abstract:The levels of sphingolipids are crucial determinants of neurodegenerative disorders. Therefore, sphingolipid levels have to be tightly regulated. The Orm protein family and ceramides act as inhibitors in the rate-limiting step of sphingolipid biosynthesis – the condensation of L-serine and palmitoyl-CoA. The two yeast isoforms Orm1 and Orm2 form a complex with the serine palmitoyltransferase (SPT). While the sequences of the Orm proteins are highly similar, however, Orm1 and Orm2 are differentially regulated in yeast cells. The mechanistic details of the differential regulation remain elusive. To elucidate the regulatory mechanism, we determined the cryo-electron microscopy structure of the SPT complex containing Orm2. Through activity assays and a newly developed plasmid coverage assay combined with targeted lipidomics, we demonstrate that the SPT complex with Orm2 exhibits lower activity in comparison to the complex containing Orm1. This collectively suggests a higher inhibitory potential of Orm2, despite the remarkably similar structures of the Orm1- and Orm2 containing complexes. The high conservation of the SPT from yeast to man implies that the three human ORMDL isoforms could also have different regulatory capacities, which might be essential to understanding their role in sphingolipid-mediated neurodegenerative disorders.

What problem does this paper attempt to address?

This paper aims to solve the problem of the regulatory mechanism of sphingolipid levels in yeast cells, especially to explore the different roles of two proteins, Orm1 and Orm2, in regulating the activity of mitogen - activated protein kinase (SPT). Specifically, by analyzing the cryo - electron microscopy structure of the SPT complex containing Orm2, combined with in vitro activity assays and a newly developed plasmid coverage assay method, the researchers revealed that Orm2 has a higher inhibitory potential than Orm1. In addition, the study also found that although the sequences of Orm1 and Orm2 are highly similar, they have functional differences in regulating SPT activity, which may be related to their slight structural differences. These findings are helpful for understanding the role of ORMDL homologs in sphingolipid - mediated neurodegenerative diseases. ### Main problems solved by the paper: 1. **Reveal the structural characteristics of Orm2 in the SPT complex and its impact on SPT activity**: By analyzing the cryo - electron microscopy structure of the SPT complex containing Orm2, the researchers found the way of interaction between Orm2 and the SPT complex and confirmed that Orm2 has a stronger ability to inhibit SPT activity than Orm1. 2. **Compare the functional differences between Orm1 and Orm2**: Although Orm1 and Orm2 are highly similar in sequence, they show different functions in regulating SPT activity. Through in vitro and in vivo experiments, the researchers verified that Orm2 has a higher inhibitory potential than Orm1. 3. **Explore the impact of phosphorylation on the function of Orm2**: By constructing a phosphorylation - mimicking mutant (Orm23D), the researchers found that phosphorylation can significantly increase the activity of SPT, indicating that phosphorylation may affect its inhibitory effect on SPT by changing the conformation of Orm2. 4. **Elucidate the conserved mechanism of sphingolipids (such as ceramide) in SPT regulation**: The study found that the binding pattern of ceramide in the SPT complex is conserved in different species, which further supports the important role of ceramide as a negative regulator of SPT activity. ### Main conclusions: - **Structural analysis**: Through cryo - electron microscopy technology, the researchers analyzed the high - resolution structure of the SPT complex containing Orm2, revealing the details of the interaction between Orm2 and the SPT complex. - **Functional differences**: In vitro and in vivo experiments show that Orm2 has a stronger ability to inhibit SPT activity than Orm1. - **Impact of phosphorylation**: The experimental results of the phosphorylation - mimicking mutant (Orm23D) show that phosphorylation can significantly increase the activity of SPT, which may be achieved by changing the conformation of Orm2. - **Conserved role of ceramide**: The study found that the binding pattern of ceramide in the SPT complex is conserved in different species, which further supports the important role of ceramide in the regulation of SPT activity. These findings not only enhance our understanding of the regulatory mechanism of sphingolipid levels in yeast cells, but also provide important clues for studying human - related diseases.

The structure of the Orm2-containing serine palmitoyltransferase complex reveals distinct inhibitory potentials of yeast Orm proteins

The structure of the Orm2-containing serine palmitoyltransferase complex reveals distinct inhibitory potentials of yeast Orm proteins.

Orm proteins control ceramide synthesis and endocytosis via LCB-mediated Ypk1 regulation

Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis

Structural insights into the assembly and substrate selectivity of human SPT–ORMDL3 complex

Structural insights into the regulation of human serine palmitoyltransferase complexes

Mechanism of sphingolipid homeostasis revealed by structural analysis of Arabidopsis SPT-ORM1 complex

The Ormdl genes regulate the sphingolipid synthesis pathway to ensure proper myelination and neurologic function in mice

Collaborative regulation of yeast SPT-Orm2 complex by phosphorylation and ceramide

Orosomucoid Proteins Interact with the Small Subunit of Serine Palmitoyltransferase and Contribute to Sphingolipid Homeostasis and Stress Responses in Arabidopsis

Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae

The ORP9-ORP11 dimer promotes sphingomyelin synthesis

Control of Mitochondria-Associated Endoplasmic Reticulum Membranes by Protein S-palmitoylation: Novel Therapeutic Targets for Neurodegenerative Diseases.

A STUDY OF ORM EXPRESSION CHANGES FUMONISIN B1-INDUCED PERTURBATIONS OF SPHINGOLIPID HOMEOSTASIS AND DIFFERENTIALLY TOUCHES CERAMIDE SYNTHASE ACTIVITIES

Orthogonal targeting of SAC1 to mitochondria implicates ORP2 as a major player in PM PI4P turnover

Structure of the yeast ceramide synthase

Orm protein phosphoregulation mediates transient sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways

Simultaneous deletion of ORMDL1 and ORMDL3 proteins disrupts immune cell homeostasis

Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicity

Regulation of ceramide biosynthesis by TOR complex 2

Unregulated Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in Nonviable Seeds with Strongly Reduced Oil Content.